Hi, what are you looking for?
Jewish Business News
Search results for "Mylan"
Business
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
Business
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Business
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
World News
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Business
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.
Business
The Perrigo stock weight in the TA-25 (derivatives) is 9.8%, second only to TEVA (10.5%).
Business
– Michael Faerm says such a move is unlikely and would not solve Teva’s growth problems. – Wells Fargo analyst Michael Faerm recommends that...
Court
– The companies have agreed to settle pending patent litigation involving Copaxone in the UK, Netherlands and France. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...